HOTAIR targets miR-126 to activate the multidrug resistance-associated protein 1/phosphatidylinositol 3-kinase (PI3-K)/Akt and thus promotes cisplatin resistance in GC. This evidence concerns the gene HOTAIR and gastric cancer.